Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Pfizer
PFE
|
$273M |
| 2 |
IBM
IBM
|
$262M |
| 3 |
Procter & Gamble
PG
|
$157M |
| 4 |
Colgate-Palmolive
CL
|
$154M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
$135M |
Top Sells
| 1 |
Verizon
VZ
|
$409M |
| 2 |
CELG
Celgene Corp
CELG
|
$233M |
| 3 |
Booking.com
BKNG
|
$123M |
| 4 |
Eli Lilly
LLY
|
$119M |
| 5 |
Kinder Morgan
KMI
|
$116M |
Sector Composition
| 1 | Technology | 15.87% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.49% |
| 5 | Consumer Staples | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ryanair
RYAAY
$32.9B
| $181M | 0.42% |
3,248,396
+22,896
| +0.7% | +$1.28M |
|
27
Cboe Global Markets
CBOE
$24.6B
| $178M | 0.41% |
3,611,700
+540,800
| +18% | +$26.6M |
|
28
Huntington Ingalls Industries
HII
$10.6B
| $168M | 0.39% |
1,774,700
+450,600
| +34% | +$42.6M |
|
29
Allegiant Air
ALGT
$1.21B
| $160M | 0.37% |
1,358,100
+29,400
| +2% | +$3.46M |
|
|
SHPG
30
DELISTED
Shire pic
SHPG
| $159M | 0.37% |
675,575
+113,875
| +20% | +$26.8M |
|
|
31
Procter & Gamble
PG
$370B
| $157M | 0.37% |
+2,001,729
| New | +$157M |
|
32
PLDT
PHI
$4.17B
| $152M | 0.36% |
2,263,100
-81,300
| -3% | -$5.48M |
|
|
CYBX
33
DELISTED
CYBERONICS INC
CYBX
| $151M | 0.35% |
2,411,201
+188,007
| +8% | +$11.7M |
|
34
Amdocs
DOX
$9.31B
| $150M | 0.35% |
3,235,600
+176,900
| +6% | +$8.2M |
|
35
Kimberly-Clark
KMB
$42.5B
| $150M | 0.35% |
1,344,400
+695,000
| +107% | +$77.3M |
|
36
Medtronic
MDT
$118B
| $147M | 0.34% |
2,312,700
+805,600
| +53% | +$51.4M |
|
|
CHK
37
DELISTED
Chesapeake Energy Corporation
CHK
| $142M | 0.33% |
4,567,500
+2,838,650
| +164% | +$88.2M |
|
|
BBBY
38
DELISTED
Bed Bath & Beyond Inc
BBBY
| $135M | 0.31% |
+2,345,860
| New | +$135M |
|
39
AstraZeneca
AZN
$255B
| $133M | 0.31% |
1,794,800
+365,800
| +26% | +$27.2M |
|
40
Exxon Mobil
XOM
$477B
| $133M | 0.31% |
+1,316,091
| New | +$133M |
|
|
PNRA
41
DELISTED
Panera Bread Co
PNRA
| $131M | 0.31% |
873,992
+223,092
| +34% | +$33.4M |
|
42
AbbVie
ABBV
$374B
| $126M | 0.29% |
2,233,600
-563,300
| -20% | -$31.8M |
|
43
Chevron
CVX
$318B
| $125M | 0.29% |
+957,284
| New | +$125M |
|
|
DTV
44
DELISTED
DIRECTV COM STK (DE)
DTV
| $125M | 0.29% |
1,468,992
+271,592
| +23% | +$23.1M |
|
|
PDLI
45
DELISTED
PDL BioPharma, Inc.
PDLI
| $125M | 0.29% |
12,896,754
+1,037,570
| +9% | +$10M |
|
46
Analog Devices
ADI
$120B
| $122M | 0.29% |
2,264,400
-349,000
| -13% | -$18.9M |
|
|
BRCM
47
DELISTED
BROADCOM CORP CL-A
BRCM
| $122M | 0.28% |
+3,285,057
| New | +$122M |
|
48
AT&T
T
$208B
| $122M | 0.28% |
3,440,604
+2,950,082
| +601% | +$104M |
|
49
Costco
COST
$421B
| $121M | 0.28% |
1,050,900
-196,900
| -16% | -$22.7M |
|
50
BCE
BCE
$22.9B
| $121M | 0.28% |
2,665,198
-341,251
| -11% | -$15.5M |
|